Feedback / Questions
Multikine (leukocyte interleukin injection) - CEL-SCI
https://www.businesswire.com/news/home/20250813431066/en/CEL-SCIs-Multikine-Head-and-Neck-Cancer-Immunotherapy-Breakthrough-Medicine-Designation-Filed-in-Saudi-Arabia-Allows-for-Patient-Access-and-ReimbursementSale-Upon-Granting-of-the-Designation-Which-Takes-Approximately-60-Days-Based-on-SFDA-Timeline
Aug 13, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next